Interesting ImagesPeyronie Disease as an Example of Nononcological, Inflammatory Uptake of 18F-Fluorocholine in Patient With Prostate CancerCegla, Paulina PhD∗; Kubiak, Anna MSc†; Witkowska, Kamila MSc‡; Czepczyński, Rafał MD, PhD‡,§Author Information From the ∗Nuclear Medicine Department †Greater Poland Cancer Registry, Greater Poland Cancer Centre ‡Nuclear Medicine Department, Affidea Poznan §Department of Endocrinology, Metabolism, and Internal Medicine, Poznan University of Medical Science, Poznan, Poland. Received for publication February 27, 2020; revision accepted March 20, 2020. Conflicts of interest and sources of founding: none declared. Correspondence to: Paulina Cegla, PhD, Department of Nuclear Medicine, Greater Poland Cancer Centre Garbary 15, 61-866 Poznan, Poland. E-mail: firstname.lastname@example.org. Clinical Nuclear Medicine: July 2020 - Volume 45 - Issue 7 - p 575-576 doi: 10.1097/RLU.0000000000003082 Buy Metrics Abstract 18F-fluorocholine PET/CT is commonly used for staging and assessing treatment response in prostate cancer patients. Growing clinical experience has shown that 18F-fluorocholine can actually accumulate in sites of inflammation. We report a rare case of a prostate cancer patient with incidentally detected Peyronie disease. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.